Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Vir Biotechnology revenue
Vir Biotechnology's revenue is $74.2 million.
What is Vir Biotechnology's revenue?
- Vir Biotechnology's revenue growth from 2018 to 2024 is 595.58%.
- Vir Biotechnology has 314 employees, and the revenue per employee ratio is $236,321.
- Vir Biotechnology's peak quarterly revenue was $1.2B in 2022(q1).
- Vir Biotechnology peak revenue was $1.6B in 2022.
- Vir Biotechnology annual revenue for 2023 was 86.2M, -94.67% growth from 2022.
- Vir Biotechnology annual revenue for 2024 was 74.2M, -13.9% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Vir Biotechnology historical revenue
Vir Biotechnology's peak revenue was $1.6B in 2022. The peak quarterly revenue was $1.2B in 2022(q1).
Vir Biotechnology's revenue increased from $10.7m in 2018 to $74.2M currently. That's a 595.58% change in annual revenue.
Vir Biotechnology annual revenue
Vir Biotechnology annual revenue over time
| Fiscal year / year | Vir Biotechnology revenue |
|---|---|
| 2018 | $10.7M |
| 2019 | $8.1M |
| 2020 | $76.4M |
| 2021 | $1.1B |
| 2022 | $1.6B |
| 2023 | $86.2M |
| 2024 | $74.2M |
How accurately did Vir Biotechnology's revenue projections match actual performance?
Vir Biotechnology annual growth
Vir Biotechnology saw the greatest revenue growth in 2021, when revenue increased by 1,334.39%.
Vir Biotechnology had the lowest revenue growth in 2019, when revenue changed by -24.16%.
Vir Biotechnology annual growth rate over time
| Year | Vir Biotechnology growth |
|---|---|
| 2019 | -24%↓ |
| 2020 | 844%↑ |
| 2021 | 1334%↑ |
| 2022 | 48%↑ |
| 2023 | -95%↓ |
| 2024 | -14%↓ |
Vir Biotechnology quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Vir Biotechnology quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | - | - | $236,427 | $370,141 |
| 2020 | $487,811 | $67.0M | $187,848 | $300,420 |
| 2021 | $605,414 | $177.1M | $103.6M | $812.7M |
| 2022 | $1.2B | ($42.6M) | $374.6M | $21.8M |
| 2023 | $46.6M | ($12.7M) | ($4.1M) | $9.6M |
| 2024 | $51.2M | $939,615 | $288,321 | $12.4M |
Vir Biotechnology jobs nearby
Do you work at Vir Biotechnology?
Is Vir Biotechnology transparent about its revenue structure?
Vir Biotechnology financial information
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 314 |
| Date Founded | 2016 |
| Headquarters | San Francisco, California |
| Number of Locations | 2 |
| Revenue | $74.2M |
| Net Income | $515,837,000 |
| Gross Proft | $73.4M (2024) |
| Tax Rate | 0.0% |
| Total Assets | $2,802,088,000 |
| Ticker | VIR |
Vir Biotechnology jobs you might like
Vir Biotechnology financing
Vir Biotechnology received early financing of $150.0M on 2017-01-06.
| Series | Round size | Date |
|---|---|---|
| Series Unknown | $150M | 01/2017 |
| Series A | $66M | 08/2018 |
| Series B | $327.6M | 01/2019 |
| Post Ipo Equity | $250M | 04/2020 |
Vir Biotechnology investors
| Investors | Security type |
|---|---|
| Altitude Life Science Ventures | Series Unknown |
| SoftBank Investment Advisers | Series Unknown |
| ARCH Venture Partners | Series Unknown |
| Alta Partners | Series Unknown |
| Bill & Melinda Gates Foundation | Series Unknown |
| SoftBank Investment Advisers | Series B |
| ARCH Venture Partners | Series B |
| Alta Partners | Series B |
| GlaxoSmithKline plc | Post Ipo Equity |
Search for jobs
Vir Biotechnology highest paying jobs
Zippia gives an in-depth look into the details of Vir Biotechnology, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Vir Biotechnology. The employee data is based on information from people who have self-reported their past or current employments at Vir Biotechnology. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Vir Biotechnology. The data presented on this page does not represent the view of Vir Biotechnology and its employees or that of Zippia.
Vir Biotechnology may also be known as or be related to VIR BIOTECHNOLOGY, INC., VIR Biotechnology, Vir Biotechnology, Vir Biotechnology Inc and Vir Biotechnology, Inc.